CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics

Genome editing allows for the precise manipulation of DNA sequences in a cell making this technology essential for understanding gene function. CRISPR/Cas9 is a targeted genome-editing platform derived from bacterial adaptive immune system and has been repurposed into a genome-editing tool. The RNA-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Debarati, Venkataramani, Prabhadevi, Nandi, Saikat, Bhattacharjee, Sonali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325665/
https://www.ncbi.nlm.nih.gov/pubmed/30636933
http://dx.doi.org/10.1186/s12935-019-0726-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325665/
https://www.ncbi.nlm.nih.gov/pubmed/30636933
http://dx.doi.org/10.1186/s12935-019-0726-0

Ejemplares similares